Description

Alceran (melfalan) powder for solution for injections 50 mg. №1 vial

Ingredients

Active ingredient: melfalan. Inactive ingredients may include mannitol and citric acid.

Dosage

Dosage: The dosage of Alceran (melfalan) is determined by a healthcare provider based on individual factors. It is typically administered as an injection into a vein. Do not self-administer without medical supervision.

Indications

Indications: Alceran (melfalan) is indicated for the treatment of multiple myeloma and ovarian cancer. It works by slowing or stopping the growth of cancer cells.

Contraindications

Contraindications: Do not use Alceran (melfalan) if you are allergic to melfalan or any of the inactive ingredients. Inform your healthcare provider about any medical conditions or medications you are taking.

Directions

Directions: Follow the instructions provided by your healthcare provider for the proper administration of Alceran (melfalan). It is important to receive this medication in a healthcare setting.

Scientific Evidence

Scientific Evidence: Studies have shown the efficacy of melfalan in the treatment of multiple myeloma and ovarian cancer. Research published in the Journal of Clinical Oncology demonstrated the effectiveness of melfalan in combination therapy for multiple myeloma patients.

Additional Information

Pharmacological Effects: Melfalan is an alkylating agent that works by damaging the DNA of cancer cells, preventing their replication. This mechanism inhibits the growth and spread of cancer cells in the body.

Clinical Trials: Clinical trials have shown that Alceran (melfalan) is well-tolerated and effective in treating certain types of cancer. A study published in the European Journal of Cancer evaluated the efficacy of melfalan in patients with advanced ovarian cancer, showing promising results in terms of tumor response rates.

Overall, Alceran (melfalan) is a vital medication in the treatment of specific cancers, backed by scientific evidence and clinical trials that support its efficacy and safety profile.